Mercer Global Advisors Inc Bio Rad Laboratories, Inc. Transaction History

Mercer Global Advisors Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$269.37 - $365.04 $219,805 - $297,872	816 New	816 $263,000
Q2 2022 Aug 10, 2022	BUY	$463.67 - $597.16 $202,623 - $260,958	437 New	437 $216,000
Q1 2022 May 10, 2022	SELL	$524.57 - $735.42 $215,598 - $302,257	-411 Closed	0 $0
Q4 2021 Feb 04, 2022	SELL	$708.84 - $794.68 $41,112 - $46,091	-58 Reduced 12.37%	411 $311,000
Q3 2021 Nov 10, 2021	SELL	$657.71 - $825.77 $103,918 - $130,471	-158 Reduced 25.2%	469 $350,000
Q2 2021 Aug 10, 2021	BUY	$576.64 - $649.04 $21,912 - $24,663	38 Added 6.45%	627 $404,000
Q1 2021 May 11, 2021	SELL	$547.01 - $662.35 $8,205 - $9,935	-15 Reduced 2.48%	589 $336,000
Q4 2020 Feb 12, 2021	BUY	$510.68 - $643.45 $308,450 - $388,643	604 New	604 $352,000

478

19.2M

15.7K

11.5K

Ticker BIO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,633,900
Market Cap $6.43B
Description
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...

Get notified when there are updates to the investment portfolio of Mercer Global Advisors Inc , based on Form 13F filings with the SEC.

Stay updated on Mercer Global Advisors Inc with notifications on news.